Trial intelligence / Profile preview

Foster versus formoterol, beclometasone, and placebo after allergen challenge in asthma

2008-002844-40Phase 4Active

Sponsor
Leiden University Medical Center
Start
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of beclometasone dipropionate + formoterol, formoterol and beclomethasone dipropionate in asthma (4 arms), sponsored by Leiden University Medical Center. Primary endpoint: Mean percent change in FEV1 during late asthmatic response. Started Dec 2008; status: active.

02

Drugs

beclometasone dipropionate + formoterolformoterolbeclomethasone dipropionate
03

Conditions

asthma

Beyond the preview

Go deeper on 2008-002844-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002844-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call